Novartis Dodges Whistleblower Lawsuit Regarding Multiple Sclerosis Drug Kickback Claims - Novartis (NYSE:NVS) - Benzinga
U.S. District Judge Kimba Wood dismissed the whistleblower lawsuit, arguing that former Novartis sales representative Steven Camburn did not provide enough detail to support his claims. Camburn's...
Read more